Back

Therapeutic potential of wild type TMEM43 overexpression in a mouse model of arrhythmogenic cardiomyopathy type 5

26 August 2022 (17:15 - 18:00)
Organised by:
Congress Presentation Part of: Models for cardiovascular diseases Cardiomyopathies ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Laura Lalaguna

Spanish National Centre for Cardiovascular Research, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Modeling cardiac fibroblast heterogeneity in fibrotic heart using human pluripotent stem cell derived epicardial cells
Doctor S. Funakoshi (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells
Doctor S. Funakoshi (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Investigations in plaque erosion and ruptured in acute coronary syndromes via novel methods in multimodal and VDJ sequencing
Miss L. De Vore (Cologne, DE)
Abstract Slides
Presentation thumbnail
Nucleic acid-based therapies using living myocardial slices
Professor C. Terracciano (London, GB)
Abstract Slides
Presentation thumbnail
Cytosolic dsRNA sensors as regulators of transgene expression from AAV vectors in human iPSC-derived cardiomyocytes
Ms I. Kraszewska (Krakow, PL)
Abstract Slides

Access the full session

Session thumbnail
Models for cardiovascular diseases

The Event

Event poster

ESC Congress 2022

26 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Session
When time is the issue
thumbnail
Congress Session
Genetics in heart failure
thumbnail
Congress Session
When external causes are the villain?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources